Skip to main content Skip to secondary navigation

News

Main content start

October 05, 2020

Jeffrey Glenn granted $14.3 million to develop broad spectrum drugs

Jeffrey Glenn

Researchers are pursuing antiviral drugs with broad efficacy against enteroviruses, which cause common colds and polio, and coronaviruses including the one that causes COVID


May 21, 2020

The Innovative Medicines Accelerator turns its focus on COVID-19

Red bridge across blue water leading to stick figure researcher with ponytail and lab coat. Blue, cloudy sky and green mountains in the distance.

Stanford’s new IMA arose before the COVID-19 pandemic struck, but now its programs are focused entirely on helping faculty generate and test new medicines to slow the spread.


February 24, 2020

ChEM-H researchers work toward new understanding of cancer camouflage

Lingyin Li (left) and Jackie Carozza (right)

A group led by ChEM-H Institute Scholar Lingyin Li and Chemistry/Biology Interface graduate student Jacqueline Carozza found a molecule that could help undermine cancer's defenses.


January 23, 2020

Antiviral treatments lead researchers to develop possible cancer drug

Jeffrey Glenn

An effort to thwart viral diseases like hepatitis or the common cold led to a new collaboration and a novel class of cancer drugs that appears effective in mice.

 


December 11, 2018

Zinc chelation may be able to deliver drug to insulin-producing cells

Micrograph of mouse pancreatic islet shows mainly black background with blue, red, and green spots.

By delivering a drug directly to beta cells, researchers may be able to spur insulin production and potentially develop a diabetes therapy in the future.

 


December 06, 2018

Researchers use zinc to target insulin-producing cells with regenerative drug

Watercolor image shows a zinc-loving chemical compound (light blue) that helps deliver drugs that trigger insulin-producing cells in the pancreas (dark blue), but not others (gray), to replicate (red)

To treat diabetes directly, doctors need a way to get drugs to cells that produce insulin. The key, Stanford researchers report, may be those cells’ affinity for zinc.

 


September 28, 2017

Stars of Stanford Medicine: “I want to leave an impact on medical care”

Three scientists wearing lab coats in a lab smile while all looking at a petri dish.

Physician-scientist Justin Annes specializes in a rare type of tumor disorders. He shares his story, and interests, in this Stars of Stanford Medicine Q&A.

 


June 09, 2014

$28 million grant launches Center of Excellence for Translation Research

Jeffrey Glenn

Jeffrey Glenn, MD, PhD, is leading a new center to develop antiviral therapies that target the host cell instead of the virus.